CLINICAL TRIALS PROFILE FOR LEVITRA
✉ Email this page to a colleague
All Clinical Trials for Levitra
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00377793 ↗ | Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II | Completed | Bayer | Phase 4 | 2006-07-01 | This trial is to provide additional important information on the impact of the treatment of the man its ED with vardenafil on partnership. This study is being run at up to 50 study centers in Europe and South Africa to evaluate the use of vardenafil in adult men with erectile dysfunction (often called impotence), and their female partner's sexual quality of life. Many men experience occasional erectile problems during their lives. However, when this becomes a continued problem, it can affect both the man and his female partner. The causes of erectile dysfunction are varied and may be due to physiological or emotional reasons. This study is designed to 1) study the effectiveness and safety of vardenafil, and 2) show whether treating a man its erectile dysfunction with vardenafil will improve his female partner its sexual quality of life. The second part (week 12) of the study (Educational program) a subgroup of subjects/couples, approximately 50% of the randomized subjects, will receive an educational program concerning ED in the from of a DVD. |
| NCT00379756 ↗ | A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia | Completed | GlaxoSmithKline | Phase 4 | 2006-05-22 | This is a study consisting of four periods (screening, run-in, treatment, follow-up). A four-week treatment-free, run-in period where the subject will make at least four attempts at intercourse on four separate days with at least 50% of the attempts must be unsuccessful. During run-in the subjects will be using a stopwatch to measure the time from erection perceived hard enough for penetration until withdrawal from the partner's vagina. Next there are 12 weeks of treatment with either placebo or LEVITRA. Each subject will be required to visit the clinic on 5 occasions over a period of 4 months. |
| NCT00443625 ↗ | Phase 1 Study of SK3530 to Investigate of the Effect of Food | Completed | SK Chemicals Co., Ltd. | Phase 1 | 2006-12-01 | This study was designed to investigate the food effect of SK3530 on the pharmacokinetics (PKs). |
| NCT00443625 ↗ | Phase 1 Study of SK3530 to Investigate of the Effect of Food | Completed | SK Chemicals Co.,Ltd. | Phase 1 | 2006-12-01 | This study was designed to investigate the food effect of SK3530 on the pharmacokinetics (PKs). |
| NCT00461565 ↗ | FDA Phase IV - Commitment - Retinal Function Study | Completed | GlaxoSmithKline | Phase 4 | 2005-02-01 | Vardenafil (Levitra) and Sildenafil (Viagra) are drugs that are marketed for use in patients with erectile dysfunction. The purpose of this study is to find out if there are any changes in the eye after taking at least 15 doses of Vardenafil and after two doses of Sildenafil. This is a double-blind study, which means that neither you nor the study doctor will know which treatment you are receiving. If you qualify for the study, you will receive:- Vardenafil 20 mg twice per week (Monday and Thursday) for a maximum of 8 weeks. There will be two times when this occurs during the study.- Sildenafil 200 mg/day for two days. There will be two times when this occurs during the study. - Placebo (a pill that looks like vardenafil or sildenafil but has no active ingredient). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Levitra
Condition Name
Clinical Trial Locations for Levitra
Trials by Country
Clinical Trial Progress for Levitra
Clinical Trial Phase
Clinical Trial Sponsors for Levitra
Sponsor Name
